← All trials
NCT06280378
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 29, 2024
- Primary completion
- May 31, 2025
- Completion date
- May 31, 2027
- First posted
- Feb 28, 2024
- Last posted
- Feb 28, 2024
- Enrollment
- 41
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kanglin Biotech (Hangzhou) Co. LTDLead sponsor
- Kanglin Biotech (Hangzhou) Co. LTDOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.